Eldred Rock Partners’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
Eldred Rock Partners's MRK Position: Q2 2026 in Review
Eldred Rock Partners increased its Merck (MRK) stake by 6.6% in Q2 2026, buying an estimated $838K and bringing the position to 116,413 shares worth $15M. The position accounts for 3.22% of the portfolio, ranked #15.
Eldred Rock Partners first reported a position in MRK in Q4 2023 and has held it in 11 quarters since. 3,814 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Eldred Rock Partners held 116,413 shares of Merck worth $15M as of Q2 2026.
- Eldred Rock Partners bought 7,161 Merck shares in Q2 2026, an estimated $838K.
- Merck made up 3.22% of Eldred Rock Partners's portfolio in Q2 2026, its #15 holding.
- Eldred Rock Partners first reported a position in Merck in Q4 2023 and has held it in 11 quarters since.
- 3,814 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Eldred Rock Partners's 13F filing for Q2 2026, filed 8 Jul 2026.